Drug
Vivaglobin
Vivaglobin: highest development phase Post-Market, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vivaglobin NCT00520494 | Post-Market | Common Variable Immunodeficiency |
Latest
No recent events.
Follow Vivaglobin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.